Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia.
Oxygen supply and diffusion into tissues are necessary for survival. The oxygen partial pressure (pO(2)), which is a key component of the physiological state of an organ, results from the balance between oxygen delivery and its consumption. In mammals, oxygen is transported by red blood cells circulating in a well-organized vasculature. Oxygen delivery is dependent on the metabolic requirements and functional status of each organ. Consequently, in a physiological condition, organ and tissue are characterized by their own unique 'tissue normoxia' or 'physioxia' status. Tissue oxygenation is severely disturbed during pathological conditions such as cancer, diabetes, coronary heart disease, stroke, etc., which are associated with decrease in pO(2), i.e. 'hypoxia'. In this review, we present an array of methods currently used for assessing tissue oxygenation. We show that hypoxia is marked during tumour development and has strong consequences for oxygenation and its influence upon chemotherapy efficiency. Then we compare this to physiological pO(2) values of human organs. Finally we evaluate consequences of physioxia on cell activity and its molecular modulations. More importantly we emphasize the discrepancy between in vivo and in vitro tissue and cells oxygen status which can have detrimental effects on experimental outcome. It appears that the values corresponding to the physioxia are ranging between 11% and 1% O(2) whereas current in vitro experimentations are usually performed in 19.95% O(2), an artificial context as far as oxygen balance is concerned. It is important to realize that most of the experiments performed in so-called normoxia might be dangerously misleading.
Centre de Biophysique Moléculaire, CNRS UPR, Orléans, France.
Aude
A
Carreau
Bouchra
B
El Hafny-Rahbi
Agata
A
Matejuk
Catherine
C
Grillon
Claudine
C
Kieda
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D015687:Cell Hypoxia / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D000860:Hypoxia / Q000097:blood* / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D008322:Mammals; D057054:Molecular Imaging; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D009593:Nitroimidazoles / Q000032:analysis; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D011048:Polarography; D049268:Positron-Emission Tomography; D054852:Small Molecule Libraries / Q000494:pharmacology
D015415:Biomarkers; D009593:Nitroimidazoles; D054852:Small Molecule Libraries; D010100:Oxygen
J Magn Reson Imaging. 1999 Dec;10(6):903-7
10581502
Mol Cancer. 2007 Jan 14;6:5
17222355
Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):619-24
18604453
J Clin Oncol. 2000 Mar;18(6):1351-9
10715308
BJU Int. 2005 Sep;96(4):540-6
16104907
Nat Rev Cancer. 2002 Sep;2(9):683-93
12209157
J Trauma. 2006 Oct;61(4):780-8; discussion 788-90
17033541
Neoplasia. 2003 Jul-Aug;5(4):308-18
14511402
NMR Biomed. 2001 Nov-Dec;14(7-8):497-506
11746943
J Surg Oncol. 1997 Sep;66(1):30-8
9290690
Antioxid Redox Signal. 2007 Aug;9(8):1221-35
17536958
Blood. 2002 Jan 1;99(1):394
11783438
Mol Pharmacol. 2005 Dec;68(6):1699-707
16141312
N Engl J Med. 1995 Mar 9;332(10):647-55
7845430
Cancer Res. 2001 Oct 15;61(20):7603-7
11606400
J Vasc Res. 2009;46(4):299-310
19077391
Am J Physiol. 1995 Jun;268(6 Pt 1):C1362-8
7541940
Mol Biotechnol. 2008 Jan;38(1):33-40
18095189
Langenbecks Arch Chir. 1985;363(3):179-84
3921788
J Biol Chem. 1987 Apr 25;262(12):5476-82
3571219
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1926-9
19204295
Anaesthesia. 2002 Nov;57(11):1128-33
12428641
Br J Cancer. 2002 Jun 17;86(12):1937-42
12085190
Anesth Analg. 1998 Aug;87(2):474-6
9706953
Eur J Haematol. 1988 Feb;40(2):126-9
3278928
Adv Exp Med Biol. 1998;454:243-52
9889898
Nat Rev Mol Cell Biol. 2004 May;5(5):343-54
15122348
Bioorg Med Chem Lett. 2005 Mar 15;15(6):1605-8
15745806
J Physiol. 2006 Mar 1;571(Pt 2):415-24
16396926
Radiol Clin North Am. 2005 Jan;43(1):221-34, xii
15693658
Arch Orthop Trauma Surg. 1988;107(2):114-6
3128962
Mol Cell Biol. 2007 Mar;27(5):1859-67
17194750
Antioxid Redox Signal. 2004 Jun;6(3):677-86
15130295
FASEB J. 2003 Feb;17(2):271-3
12490539
Br J Cancer. 1968 Jun;22(2):258-73
5660132
Anaesthesia. 2002 Feb;57(2):110-5
11871946
Radiat Res. 1993 Dec;136(3):422-34
8278585
Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):95-103
8175452
Biochem J. 1994 Jun 1;300 ( Pt 2):525-30
8002959
Radiother Oncol. 1999 May;51(2):179-85
10435811
Croat Med J. 2006 Apr;47(2):246-52
16625689
Br J Anaesth. 2004 May;92(5):735-7
15033887
Anasthesiol Intensivmed Notfallmed Schmerzther. 1995 Apr;30(2):108-10
7772654
Eur J Nucl Med. 1995 Mar;22(3):265-80
7789400
Circ Res. 2009 Feb 27;104(4):442-54
19246688
Annu Rev Pharmacol Toxicol. 2002;42:283-323
11807174
Cell. 2003 Jun 13;113(6):673-6
12809598
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13459-64
12351678
Adv Exp Med Biol. 1994;345:567-74
8079759
Int J Radiat Oncol Biol Phys. 1984 Mar;10(3):425-9
6231272
J Clin Oncol. 2005 Dec 20;23(36):9097-104
16361616
Acta Physiol Scand. 2000 Apr;168(4):615-22
10759598
Q J Nucl Med Mol Imaging. 2009 Apr;53(2):193-200
19293767
Nature. 1996 Jan 4;379(6560):88-91
8538748
J Surg Res. 2007 Aug;141(2):247-51
17512550
Acta Med Scand. 1976;199(3):185-90
3948
Magn Reson Med. 2002 Dec;48(6):980-6
12465107
Anesth Analg. 1996 Mar;82(3):582-6
8623965
J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
17895480
Semin Nucl Med. 1985 Oct;15(4):377-94
3904006
Scand J Med Sci Sports. 2001 Aug;11(4):213-22
11476426
Arch Emerg Med. 1989 Sep;6(3):172-82
2675881
Exp Cell Res. 2011 Jan 1;317(1):29-41
20813110
N Engl J Med. 1989 Oct 26;321(17):1174-8
2571931
Antioxid Redox Signal. 2007 Aug;9(8):1207-19
17536959
Acta Neurochir Suppl (Wien). 1993;59:58-63
7906079
Drug Metab Rev. 2002 Aug;34(3):581-92
12214668
J Physiol. 2003 Jun 15;549(Pt 3):855-63
12702744
Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1239-42
3744945
J Antibiot (Tokyo). 1953 Dec;6(4):182
13152032
Cell Death Differ. 2008 Apr;15(4):667-71
18219318
Neoplasia. 2010 Sep;12(9):755-65
20824052
Blood. 2009 Feb 12;113(7):1504-12
18957686
J Comput Assist Tomogr. 1988 Sep-Oct;12(5):824-35
3170845
Biochem J. 1981 Nov 15;200(2):247-55
7340832
Cancer Res. 2002 Sep 15;62(18):5248-53
12234992
Cancer Res. 2003 Nov 1;63(21):7284-90
14612525
Blood. 1993 Dec 15;82(12):3610-5
8260699
Neurosurgery. 1998 Nov;43(5):1082-95
9802852
Clin Cancer Res. 2006 Mar 1;12(5):1507-14
16533775
Cell Cycle. 2007 Apr 15;6(8):919-26
17404509
J Neurooncol. 2009 May;92(3):317-35
19357959
Am J Physiol. 1983 Sep;245(3):H513-8
6412569
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15576-81
17028170
Semin Oncol. 2001 Apr;28(2 Suppl 8):36-41
11395851
Cancer Sci. 2009 Aug;100(8):1366-73
19459851
Adv Exp Med Biol. 1990;277:507-14
2096655
Br J Radiol. 1999 Jul;72(859):627-30
10624317